"In STOP COVID, a contactless, double-blind randomized placebo-controlled trial conducted in the United States among nonhospitalized adults with mild COVID-19 diagnosed within 7 days of symptom onset, fluvoxamine (100 mg up to 3 times daily for 15 days) reduced clinical deterioration at Day 15."
Mechanisms of action of fluvoxamine for COVID-19: a historical review
"...Drug repurposing for the COVID-19 pandemic has received particular attention. Increasing clinical data suggest that antidepressant use in early-stage subjects with COVID-19 might be associated with a reduced risk of intubation or death. Among the antidepressants, fluvoxamine is the most attractive drug for mild to moderate subjects with COVID-19."
Oh wait. I found these: (Remember - Luvox is the same drug as Fluvoxamine)
Fluvoxamine | COVID-19 Treatment Guidelines
https://www.covid19treatmentguidelines.nih.gov
"In STOP COVID, a contactless, double-blind randomized placebo-controlled trial conducted in the United States among nonhospitalized adults with mild COVID-19 diagnosed within 7 days of symptom onset, fluvoxamine (100 mg up to 3 times daily for 15 days) reduced clinical deterioration at Day 15."
Mechanisms of action of fluvoxamine for COVID-19: a historical review
https://www.nature.com/articles/s41380-021-01432-3
"...Drug repurposing for the COVID-19 pandemic has received particular attention. Increasing clinical data suggest that antidepressant use in early-stage subjects with COVID-19 might be associated with a reduced risk of intubation or death. Among the antidepressants, fluvoxamine is the most attractive drug for mild to moderate subjects with COVID-19."
https://ipfs.io/ipfs/QmdhNBL25WySAMW9rsohvC3QpVnFUocSiwCQcsuEvyeew8/image.png
Yup Yup, this.